Valuation: Arcoma AB

Market Cap 115M 11.93M 10.4M 9.71M 8.92M 16.75M 1.14B 17.17M 44.97M 567M 44.79M 43.82M 1.96B P/E 2024
12.7x
P/E 2025 20.9x
Enterprise Value 79.81M 8.28M 7.22M 6.73M 6.19M 11.62M 792M 11.91M 31.2M 393M 31.08M 30.4M 1.36B EV / Sales 2024
0.82x
EV / Sales 2025 0.53x
Free-Float
52.21%
Yield 2024 *
-
Yield 2025 -
1 day+0.25%
1 week-4.74%
Current month-9.87%
1 month-8.64%
3 months+8.06%
6 months+7.77%
Current year+9.54%
1 week 7.96
Extreme 7.96
8.4
1 month 7.02
Extreme 7.02
8.96
Current year 6.16
Extreme 6.16
10.05
1 year 6.16
Extreme 6.16
11
3 years 6.16
Extreme 6.16
18.3
5 years 6.16
Extreme 6.16
20.2
10 years 3.57
Extreme 3.57
26.3
Manager TitleAgeSince
Chief Executive Officer 45 31/12/2022
Director of Finance/CFO 42 31/12/2021
Chief Tech/Sci/R&D Officer - 31/05/2026
Director TitleAgeSince
Director/Board Member 55 31/12/2011
Chairman 54 31/12/2016
Director/Board Member 59 31/12/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%-4.74%-20.79%-10.17% 11.84M
+2.70%-0.47%-17.23%-21.68% 13.44B
+0.07%-8.14%+39.48%-12.31% 3.99B
-0.60%-0.75%+65.05%+114.72% 1.21B
+1.46%+2.25%-39.18%-59.33% 1.21B
+2.46%+3.43%-38.94%-47.00% 1.1B
+2.86%-2.96%-45.13% - 907M
-0.61%-1.93%+25.62%+80.83% 468M
+0.15%-5.56%+52.41% - 331M
-2.71%-10.44%-62.26%+196.20% 250M
Average +0.60%-1.85%-4.10%+30.16% 2.29B
Weighted average by Cap. +1.83%-0.64%-4.92%-10.98%

Financials

2024 2025
Net sales 157M 16.27M 14.18M 13.23M 12.16M 22.84M 1.56B 23.4M 61.3M 773M 61.06M 59.73M 2.68B 131M 13.57M 11.83M 11.04M 10.15M 19.05M 1.3B 19.52M 51.13M 644M 50.93M 49.83M 2.23B
Net income 11.18M 1.16M 1.01M 943K 867K 1.63M 111M 1.67M 4.37M 55.08M 4.35M 4.26M 191M 5.03M 522K 455K 424K 390K 733K 49.89M 751K 1.97M 24.78M 1.96M 1.92M 85.89M
Net Debt -13.32M -1.38M -1.2M -1.12M -1.03M -1.94M -132M -1.99M -5.21M -65.61M -5.19M -5.07M -227M -35.23M -3.65M -3.19M -2.97M -2.73M -5.13M -349M -5.26M -13.77M -174M -13.72M -13.42M -602M
Logo Arcoma AB
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Employees
31
Date Price Change Volume
29/07/26 SEK 8.040 +0.25% 2,500
28/07/26 SEK 8.020 -3.14% 16,684
27/07/26 SEK 8.280 -0.72% 1,910
24/07/26 SEK 8.340 +3.99% 146
23/07/26 SEK 8.020 +0.75% 1,020

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARCOMA Stock